Trials / Completed
CompletedNCT02257957
Platelet -Rich Plasma (PRP) Injection for the Treatment of Severe Dry Eye
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Universidad Nacional de Colombia · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Dry eye is a chronic condition that decreases function and affect visual function with severe discapacity until now treatments are based in artificial eye drops. Platelet rich plasma has emerged as a strategy for cellular restoration, the purpose of this study is to evaluate their effects in lacrimal production and safety of this intervention in patients with severe dry eye.
Detailed description
Dry eye is a chronic condition that decreases function and affect visual function with severe discapacity until now treatments are based in artificial eye drops. Platelet rich plasma has emerged as a strategy for cellular restoration, the purpose of this study is to evaluate their effects in lacrimal production and safety of this intervention in patients with severe dry eye.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | PRP injection | |
| DRUG | Standard care Hyaluronic acid eye drops | : 15 patients with diagnosis of severe dry eye will receive standard of care treatment ( Hyaluronic acid eye drops 5 times per day). Objective measurements as corneal staining, Shirmer , BUT, and VA, will be determinate as subjective measurements as OSDI and treatment compliance will be evaluated at day 0-30,60 and 90 |
Timeline
- Start date
- 2014-11-30
- Primary completion
- 2015-09-30
- Completion
- 2016-04-20
- First posted
- 2014-10-07
- Last updated
- 2021-08-24
- Results posted
- 2021-08-24
Source: ClinicalTrials.gov record NCT02257957. Inclusion in this directory is not an endorsement.